SU 5205
SU 5205 Basic information
- Product Name:
- SU 5205
- Synonyms:
-
- SU 5205
- 2H-Indol-2-one, 3-[(4-fluorophenyl)methylene]-1,3-dihydro-
- SU 5205; SU-5205; SU5205
- mitogenesis,Inhibitor,VEGFR2,Vascular endothelial growth factor receptor,FLK-1,SU-5205,endothelial,VEGFR,SU5205,inhibit
- SU5205, 10 mM in DMSO
- (z)-3-(4-fluorobenzylidene)indolin-2-one
- CAS:
- 3476-86-6
- MF:
- C15H10FNO
- MW:
- 239.24
- Mol File:
- 3476-86-6.mol
SU 5205 Chemical Properties
- Melting point:
- 194-196 °C
- Boiling point:
- 435.3±45.0 °C(Predicted)
- Density
- 1.306±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMF: 50 mg/ml; DMSO: 50 mg/ml; DMSO:PBS(pH 7.2) (1:3): 0.25 mg/ml; Ethanol: 5 mg/ml
- form
- A crystalline solid
- pka
- 12.69±0.20(Predicted)
- color
- White to yellow
SU 5205 Usage And Synthesis
Uses
SU5205 is an inhibitor of VEGFR2 (FLK-1), with an IC50 of 9.6 μM[1].
Biological Activity
SU5205 is an inhibitor of VEGF receptor 2 (VEGFR2/FLK-1) with IC50 of 9.6 μM.
Synthesis
59-48-3
459-57-4
3476-86-6
GENERAL STEPS: 2-Indolone (1 eq.) and p-fluorobenzaldehyde (1 eq.) were added to ethanol (EtOH, 3 mL/0.2 mmol) and the mixture was stirred until completely dissolved. Subsequently piperidine (0.1 eq.) was added and the reaction mixture was heated to 90 °C and kept reacting for 3-7 hours. After completion of the reaction, it was cooled to room temperature. The resulting precipitate was collected by filtration, washed with cold ethanol and dried to give 3-(4-fluorophenylmethylene)indolin-2-one crude. If further purity is required, the product can be purified by ethanol recrystallization.
in vitro
SU5205 inhibits ligand-induced endothelial mitogenesis for VEGF with an IC 50 of 5.1 μM.
target
| Target | Value |
| VEGFR2 (Cell-free assay) | 9.6 μM |
IC 50
Flk-1: 9.6 μM (IC50)
References
[1] Huh S, et al. Melanogenesis inhibitory effect of fatty acid alkyl esters isolated from Oxalis triangularis. Biol Pharm Bull. 2010;33(7):1242-5. DOI:10.1248/bpb.33.1242
[2] Torsten K, et, al. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor. Bioorg Med Chem. 2009 Nov 15; 17(22): 7732-42.
SU 5205Supplier
- Tel
- 025-66113011 17798518460
- cfzhang@aikonchem.com
- Tel
- 13621943973
- sales@shjiyipharmatech.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 15076683720
- klq@cw-bio.com
- Tel
- 021-QQ:65489617 15618227136
- Sales@ATKchemical.com
SU 5205(3476-86-6)Related Product Information
- SU 5416
- SU4312
- SU 9516
- su5204
- SU5208
- 5-CHLORO-3-[(3,5-DIMETHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE
- VEGFR2 Kinase Inhibitor I
- IC 261
- NSC 247030
- SU 5214
- 3-(4-ISOPROPYLBENZYLIDENYL)INDOLIN-2-ONE
- SUN11602
- SU 4942
- SU 11274
- (E)-2-cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
- SU 4312